Bio

Dr. Plante obtained her medical degree from Laval University in 1985 and completed her residency in obstetrics and gynecology at McGill University in 1990. She continued with a 3-year subspecialty in gynecologic oncology at the Memorial Sloan-Kettering Cancer Center in New York in 1993. Since then, she has worked as a gynecologist-oncologist at l’Hôtel-Dieu de Québec.

Dr. Plante is a Professor in the Department of Obstetrics and Gynecology at Laval University. She is head of the oncology-gynecology department and in charge of clinical research at l’Hôtel-Dieu de Québec.

Expertise

  1. Plante is best known for her expertise in minimally invasive surgery in the treatment of gynecological cancers, including robot-assisted surgery, the sentinel lymph node technique in gynecological cancers and in surgeries aimed at preserving fertility in young women suffering from cervical cancer, including radical trachelectomy.
  2. Plante is the principal investigator of a large international, prospective and randomized study led by the Canadian Cancer Trials Group (CCTG) and the Gynecologic Cancer InterGroup (GCIG) (CX-5 or SHAPE study). The study aims to randomize patients with early-stage and low-risk cervical cancer to receive either radical hysterectomy (standard) or simple hysterectomy (studied). More than 700 patients will be randomized in this study.
  3. In addition, Dr. Plante is particularly interested in oncogenetics related to ovarian cancer. She has been involved in the activities of the oncogenetics department, along with the St-Sacrement Hospital team, since its inception, and is responsible for its ovarian component.

Recent Appointments

  1. Co-chair of CCRN (Cervical Cancer Research Network)
  2. Chair, International Committee, SGO (Society of Gynecologic Oncology)
  3. Co-chair, Cervix Working Group, CCTG
  4. Member, Editorial Board, International Journal of Gynecologic Cancer (IJGC) and Journal of Obstetrics and Gynecology of Canada (JOGC)
L'Hôtel-Dieu de Québec
11, côte du Palais
Québec, Québec
Canada G1R 2J6

Latest news

Data not available

152 entries « 1 of 16 »

Trudel D, Avarvarei LM, Orain M, Turcotte S, Plante M, Gregoire J, Kappelhoff R, Labbe DP, Bachvarov D, Tetu B, Overall CM, Bairati I

Proteases and their inhibitors as prognostic factors for high-grade serous ovarian cancer.

Journal Article

Pathol Res Pract, 215 (6), pp. 152369, 2019, ISSN: 0344-0338.

Abstract | Links:

Renaud MC, Belanger L, Lachapelle P, Gregoire J, Sebastianelli A, Plante M

Effectiveness of an Enhanced Recovery After Surgery Program in Gynaecology Oncologic Surgery: A Single-Centre Prospective Cohort Study.

Journal Article

J Obstet Gynaecol Can, 41 (4), pp. 436-442, 2019, ISSN: 1701-2163.

Abstract | Links:

Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB, Prat J, Sankaranarayanan R, Brierley J, Mutch D, Querleu D, Cibula D, Quinn M, Botha H, Sigurd L, Rice L, Ryu HS, Ngan H, Maenpaa J, Andrijono A, Purwoto G, Maheshwari A, Bafna UD, Plante M, Natarajan J

Revised FIGO staging for carcinoma of the cervix uteri.

Journal Article

Int J Gynaecol Obstet, 145 (1), pp. 129-135, 2019, ISSN: 0020-7292.

Abstract | Links:

Lecuru FR, McCormack M, Hillemanns P, Anota A, Leitao M, Mathevet P, Zweemer R, Fujiwara K, Zanagnolo V, Zahl Eriksson AG, Hudson E, Ferron G, Plante M

SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study.

Journal Article

Int J Gynecol Cancer, 29 (4), pp. 829-834, 2019, ISSN: 1048-891X.

Abstract | Links:

Plante M, van Trommel N, Lheureux S, Oza AM, Wang L, Sikorska K, Ferguson SE, Han K, Amant F

FIGO 2018 stage IB2 (2-4 cm) Cervical cancer treated with Neo-adjuvant chemotherapy followed by fertility Sparing Surgery (CONTESSA); Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility (NEOCON-F). A PMHC, DGOG, GCIG/CCRN and multicenter study.

Journal Article

Int J Gynecol Cancer, 29 (5), pp. 969-975, 2019, ISSN: 1048-891X.

Abstract | Links:

Furrer D, Gregoire J, Turcotte S, Plante M, Bachvarov D, Trudel D, Tetu B, Douville P, Bairati I

Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.

Journal Article

PLoS ONE, 14 (6), pp. e0218621, 2019.

Abstract | Links:

Gagne A, Tetu B, Orain M, Turcotte S, Plante M, Gregoire J, Renaud MC, Bairati I, Trudel D

Correction to: HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis.

Journal Article

Diagn Pathol, 13 (1), pp. 75, 2018.

Abstract | Links:

Gagne A, Tetu B, Orain M, Turcotte S, Plante M, Gregoire J, Renaud MC, Bairati I, Trueel D

HtrA1 expression and the prognosis of high-grade serous ovarian carcinoma: a cohort study using digital analysis.

Journal Article

Diagn Pathol, 13 (1), pp. 57, 2018.

Abstract | Links:

Ager BJ, Gallardo-Rincon D, de Leon DC, Chavez-Blanco A, Chuang L, Duenas-Gonzalez A, Gomez-Garcia E, Jerez R, Jhingran A, McCormack M, Mileshkin L, Perez-Plasencia C, Plante M, Poveda A, Gaffney DK

Advancing clinical research globally: Cervical cancer research network from Mexico.

Journal Article

Gynecol Oncol Rep, 25 , pp. 90-93, 2018, ISSN: 2352-5789.

Abstract | Links:

McCluggage WG, Judge MJ, Alvarado-Cabrero I, Duggan MA, Horn LC, Hui P, Ordi J, Otis CN, Park KJ, Plante M, Stewart CJR, Wiredu EK, Rous B, Hirschowitz L

Data Set for the Reporting of Carcinomas of the Cervix: Recommendations From the International Collaboration on Cancer Reporting (ICCR).

Journal Article

Int J Gynecol Pathol, 37 (3), pp. 205-228, 2018, ISSN: 0277-1691.

Abstract | Links:

152 entries « 1 of 16 »
Signaler des ajouts ou des modifications

Active projects

  • Centre de recherche du CHU de Québec - Université Laval, Subvention, Centre hospitalier universitaire de Québec - Université Laval, Centres de recherche affiliés, from 2017-01-01 to 2099-12-31
  • Randomized trial comparing radical hysterectomy and pelvic node dissection vs simple hysterectomy and pelvic node dissection in patients with low risk cervical cancer defined as lesions measuring less than 2 cm with less than 50% stromal in, Subvention, Instituts de recherche en santé du Canada, Subvention de fonctionnement, from 2012-03-31 to 2020-03-31
Data provided by the Université Laval research projects registery